For patients with moderately to severely active systemic lupus erythematosus (SLE), anifrolumab is associated with l ...

Lupus can do irreversible harm to a person's organs, damaging the lungs, kidneys, heart, liver and other vital organs through ...

In the United States, SLE treatment trends between 2007 and 2023 show a continued reliance on glucocorticoids, despite advances in steroid-sparing agents.

The Lupus Foundation of America is a nonprofit whose mission is to "improve the quality of life for all people affected by ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

People with lupus are at an increased risk of depression. Lupus is a chronic condition with recurring symptoms that can ...

Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...

EXCLUSIVE: Loose Women star Kelly Bryan opened up about her ongoing battle with lupus - a condition she has been living with ...

Roche’s Gazyva/Gazyvaro (obinutuzumab) has demonstrated superiority over standard therapy in patients with active lupus ...

While Roche’s Gazyva has been on the market for a dozen years and has won four approvals from the FDA, it is making a late ...

Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

Children with lupus nephritis who receive belimumab achieve treatment targets faster, and can taper glucocorticoids earlier, than those using standard immunotherapy, according to data published in ...